Literature DB >> 33480129

Transient deSUMOylation of IRF2BP proteins controls early transcription in EGFR signaling.

Sina V Barysch1, Nicolas Stankovic-Valentin1, Tim Miedema1, Samir Karaca2, Judith Doppel1, Thiziri Nait Achour1, Aarushi Vasudeva1, Lucie Wolf3,4, Carsten Sticht5, Henning Urlaub2,6, Frauke Melchior1.   

Abstract

Molecular switches are essential modules in signaling networks and transcriptional reprogramming. Here, we describe a role for small ubiquitin-related modifier SUMO as a molecular switch in epidermal growth factor receptor (EGFR) signaling. Using quantitative mass spectrometry, we compare the endogenous SUMO proteomes of HeLa cells before and after EGF stimulation. Thereby, we identify a small group of transcriptional coregulators including IRF2BP1, IRF2BP2, and IRF2BPL as novel players in EGFR signaling. Comparison of cells expressing wild type or SUMOylation-deficient IRF2BP1 indicates that transient deSUMOylation of IRF2BP proteins is important for appropriate expression of immediate early genes including dual specificity phosphatase 1 (DUSP1, MKP-1) and the transcription factor ATF3. We find that IRF2BP1 is a repressor, whose transient deSUMOylation on the DUSP1 promoter allows-and whose timely reSUMOylation restricts-DUSP1 transcription. Our work thus provides a paradigm how comparative SUMO proteome analyses serve to reveal novel regulators in signal transduction and transcription.
© 2021 The Authors. Published under the terms of the CC BY 4.0 license.

Entities:  

Keywords:  ATF3; DUSP1; EGFR; IRF2BP1; SUMO

Mesh:

Substances:

Year:  2021        PMID: 33480129      PMCID: PMC7926235          DOI: 10.15252/embr.201949651

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  70 in total

1.  Loss of VGLL4 suppresses tumor PD-L1 expression and immune evasion.

Authors:  Ailing Wu; Qingzhe Wu; Yujie Deng; Yuning Liu; Jinqiu Lu; Liansheng Liu; Xiaoling Li; Cheng Liao; Bin Zhao; Hai Song
Journal:  EMBO J       Date:  2018-11-05       Impact factor: 11.598

2.  TIF1γ requires sumoylation to exert its repressive activity on TGFβ signaling.

Authors:  Laurent Fattet; Anne-Sophie Ay; Benjamin Bonneau; Laurent Jallades; Ivan Mikaelian; Isabelle Treilleux; Germain Gillet; Cédric Hesling; Ruth Rimokh
Journal:  J Cell Sci       Date:  2013-06-20       Impact factor: 5.285

3.  Identification of PCTA, a TGIF antagonist that promotes PML function in TGF-beta signalling.

Authors:  Nourdine Faresse; Frédéric Colland; Nathalie Ferrand; Céline Prunier; Marie-Francoise Bourgeade; Azeddine Atfi
Journal:  EMBO J       Date:  2008-05-29       Impact factor: 11.598

4.  IRF2BP2 modulates the crosstalk between glucocorticoid and TNF signaling.

Authors:  A B M Kaiser Manjur; Joanna K Lempiäinen; Marjo Malinen; Jorma J Palvimo; Einari A Niskanen
Journal:  J Steroid Biochem Mol Biol       Date:  2019-05-28       Impact factor: 4.292

5.  Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity.

Authors:  R Dixon Dorand; Joseph Nthale; Jay T Myers; Deborah S Barkauskas; Stefanie Avril; Steven M Chirieleison; Tej K Pareek; Derek W Abbott; Duncan S Stearns; John J Letterio; Alex Y Huang; Agne Petrosiute
Journal:  Science       Date:  2016-07-21       Impact factor: 47.728

6.  Identification of novel co-repressor molecules for Interferon Regulatory Factor-2.

Authors:  Kay S Childs; Stephen Goodbourn
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

7.  Hepatic IRF2BP2 Mitigates Nonalcoholic Fatty Liver Disease by Directly Repressing the Transcription of ATF3.

Authors:  Jing Fang; Yan-Xiao Ji; Peng Zhang; Lin Cheng; Yue Chen; Jun Chen; Yanfang Su; Xu Cheng; Yan Zhang; Tianyu Li; Xuehai Zhu; Xiao-Jing Zhang; Xiang Wei
Journal:  Hepatology       Date:  2020-01-30       Impact factor: 17.425

8.  NLS-tagging: an alternative strategy to tag nuclear proteins.

Authors:  Guillaume Giraud; Ralph Stadhouders; Andrea Conidi; Dick H W Dekkers; Danny Huylebroeck; Jeroen A A Demmers; Eric Soler; Frank G Grosveld
Journal:  Nucleic Acids Res       Date:  2014-09-26       Impact factor: 16.971

9.  The endosomal transcriptional regulator RNF11 integrates degradation and transport of EGFR.

Authors:  Sandra Scharaw; Murat Iskar; Alessandro Ori; Gaelle Boncompain; Vibor Laketa; Ina Poser; Emma Lundberg; Franck Perez; Martin Beck; Peer Bork; Rainer Pepperkok
Journal:  J Cell Biol       Date:  2016-11-08       Impact factor: 10.539

10.  Interferon regulatory factor 2 binding protein 2b regulates neutrophil versus macrophage fate during zebrafish definitive myelopoiesis.

Authors:  Luxiang Wang; Shuo Gao; Haihong Wang; Chang Xue; Xiaohui Liu; Hao Yuan; Zixuan Wang; Saijuan Chen; Zhu Chen; Hugues de Thé; Yiyue Zhang; Wenqing Zhang; Jun Zhu; Jun Zhou
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

View more
  3 in total

Review 1.  Regulation of SUMOylation Targets Associated With Wnt/β-Catenin Pathway.

Authors:  Linlin Fan; Xudong Yang; Minying Zheng; Xiaohui Yang; Yidi Ning; Ming Gao; Shiwu Zhang
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

2.  Transient deSUMOylation of IRF2BP proteins controls early transcription in EGFR signaling.

Authors:  Sina V Barysch; Nicolas Stankovic-Valentin; Tim Miedema; Samir Karaca; Judith Doppel; Thiziri Nait Achour; Aarushi Vasudeva; Lucie Wolf; Carsten Sticht; Henning Urlaub; Frauke Melchior
Journal:  EMBO Rep       Date:  2021-01-22       Impact factor: 8.807

3.  Loss of IRF2BPL impairs neuronal maintenance through excess Wnt signaling.

Authors:  Paul C Marcogliese; Debdeep Dutta; Shrestha Sinha Ray; Nghi D P Dang; Zhongyuan Zuo; Yuchun Wang; Di Lu; Fatima Fazal; Thomas A Ravenscroft; Hyunglok Chung; Oguz Kanca; JiJun Wan; Emilie D Douine; Undiagnosed Diseases Network; Loren D M Pena; Shinya Yamamoto; Stanley F Nelson; Matthew Might; Kathrin C Meyer; Nan Cher Yeo; Hugo J Bellen
Journal:  Sci Adv       Date:  2022-01-19       Impact factor: 14.136

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.